Related Experiment Video

Updated: Mar 22, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence

Zhao Wang1, Young-Seok Cho, Tsunenari Soeda

  • 1aResearch Laboratory of Electronics, Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge bCardiology Division cMGH Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA dDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China eDivision of Cardiology, Kyung Hee University, Seoul, South Korea.

Coronary Artery Disease
|April 23, 2016
PubMed

Insights

High-intensity statin therapy significantly improved fibrous cap stabilization in coronary artery disease patients. A novel 3D analysis revealed dose-dependent effects, offering deeper insights into plaque changes with statins.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Engineering
  • Pharmacology

Background:

  • Statin therapy is known to reduce LDL cholesterol and cardiovascular events.
  • The precise mechanisms by which statins stabilize atherosclerotic plaques, particularly fibrous caps, remain incompletely understood.
  • Understanding dose-dependent effects is crucial for optimizing cardiovascular risk management.

Purpose of the Study:

  • To investigate the three-dimensional (3D) morphological changes of fibrous caps in lipid plaques in response to varying intensities of statin therapy.
  • To explore the dose-dependent relationship between atorvastatin dosage and fibrous cap stabilization.
  • To evaluate a novel 3D computer algorithm for analyzing plaque phenotype changes over time.

Main Methods:

  • A novel 3D computer algorithm was used to analyze changes in fibrous cap morphology.
  • Patients with coronary artery disease received either moderate (atorvastatin 20 mg/day) or high-intensity (atorvastatin 60 mg/day) statin therapy.
  • Optical coherence tomography (OCT) data were collected at baseline, 6 months, and 12 months for 31 lipid plaques in 21 patients.

Main Results:

  • Conventional 2D metrics like minimum fibrous cap thickness did not show significant differences between treatment groups.
  • The 3D analysis revealed significant, dose-dependent differences in thin cap (<80 μm) surface area changes between moderate and high-intensity statin groups (P<0.001).
  • 3D reconstructions demonstrated complex and diverse patterns of fibrous cap evolution.

Conclusions:

  • High-intensity statin therapy demonstrated superior efficacy in stabilizing fibrous caps compared to moderate-intensity therapy.
  • The novel 3D algorithm provides a more comprehensive assessment of plaque phenotype changes in response to statin treatment.
  • These findings enhance our understanding of the mechanisms underlying statin-induced plaque stabilization.
Abstract

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

4.7K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.6K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
937
Inflammation01:38

Inflammation

Overview
64.0K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.9K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395